Rita J Desai

Array ( [id] => 630453 [patent_doc_number] => 07132414 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-11-07 [patent_title] => 'Pharmaceutical compositions containing 3-aminoazetidine derivatives, novel derivatives and their preparation' [patent_app_type] => utility [patent_app_number] => 10/771764 [patent_app_country] => US [patent_app_date] => 2004-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13038 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/132/07132414.pdf [firstpage_image] =>[orig_patent_app_number] => 10771764 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 535750 [patent_doc_number] => 07176212 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-02-13 [patent_title] => '2,4-diamino pyrimidine compounds having anti-cell proliferative activity' [patent_app_type] => utility [patent_app_number] => 10/771118 [patent_app_country] => US [patent_app_date] => 2004-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29862 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/176/07176212.pdf [firstpage_image] =>[orig_patent_app_number] => 10771118 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 446532 [patent_doc_number] => 07253187 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-08-07 [patent_title] => 'Heterocyclic inhibitors of ERK2 and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/770814 [patent_app_country] => US [patent_app_date] => 2004-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30475 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/253/07253187.pdf [firstpage_image] =>[orig_patent_app_number] => 10770814 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7351753 [patent_doc_number] => 20040248884 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-09 [patent_title] => 'Novel cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors' [patent_app_type] => new [patent_app_number] => 10/770382 [patent_app_country] => US [patent_app_date] => 2004-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 108751 [patent_no_of_claims] => 75 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20040248884.pdf [firstpage_image] =>[orig_patent_app_number] => 10770382 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7432956 [patent_doc_number] => 20040162303 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-19 [patent_title] => '4-aminopyrimidine-5-one derivatives' [patent_app_type] => new [patent_app_number] => 10/770379 [patent_app_country] => US [patent_app_date] => 2004-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 54871 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20040162303.pdf [firstpage_image] =>[orig_patent_app_number] => 10770379 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7672713 [patent_doc_number] => 20040181066 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-16 [patent_title] => 'Tyrosine kinase inhibitors' [patent_app_type] => new [patent_app_number] => 10/485291 [patent_app_country] => US [patent_app_date] => 2004-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20304 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20040181066.pdf [firstpage_image] =>[orig_patent_app_number] => 10485291 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7306228 [patent_doc_number] => 20040116448 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-17 [patent_title] => 'Substances for the therapy of diseases caused by highly proliferating cells' [patent_app_type] => new [patent_app_number] => 10/474318 [patent_app_country] => US [patent_app_date] => 2004-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 25440 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0116/20040116448.pdf [firstpage_image] =>[orig_patent_app_number] => 10474318 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7265077 [patent_doc_number] => 20040242613 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-02 [patent_title] => 'Pyrimidine derivatives useful as inhibitors of PKC-theta' [patent_app_type] => new [patent_app_number] => 10/766079 [patent_app_country] => US [patent_app_date] => 2004-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17709 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20040242613.pdf [firstpage_image] =>[orig_patent_app_number] => 10766079 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7677119 [patent_doc_number] => 20040152707 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-05 [patent_title] => 'High affinity ligands for nociceptin receptor ORL-1' [patent_app_type] => new [patent_app_number] => 10/761977 [patent_app_country] => US [patent_app_date] => 2004-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 18271 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20040152707.pdf [firstpage_image] =>[orig_patent_app_number] => 10761977 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5023534 [patent_doc_number] => 20070149500 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-28 [patent_title] => 'Compounds, compositions, and methods' [patent_app_type] => utility [patent_app_number] => 10/541441 [patent_app_country] => US [patent_app_date] => 2004-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24873 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0149/20070149500.pdf [firstpage_image] =>[orig_patent_app_number] => 10541441 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7288833 [patent_doc_number] => 20040147742 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-29 [patent_title] => 'Pyrimidine spirobifluorene oligomer for organic light-emitting device' [patent_app_type] => new [patent_app_number] => 10/759046 [patent_app_country] => US [patent_app_date] => 2004-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 4240 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20040147742.pdf [firstpage_image] =>[orig_patent_app_number] => 10759046 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 627083 [patent_doc_number] => 07135467 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-11-14 [patent_title] => 'HIV integrase inhibitors' [patent_app_type] => utility [patent_app_number] => 10/755642 [patent_app_country] => US [patent_app_date] => 2004-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29209 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/135/07135467.pdf [firstpage_image] =>[orig_patent_app_number] => 10755642 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7411768 [patent_doc_number] => 20040106632 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-03 [patent_title] => 'Salt of thiazolidinedione and its polymorphs as antidiabetic agents and method for obtaining them' [patent_app_type] => new [patent_app_number] => 10/470980 [patent_app_country] => US [patent_app_date] => 2004-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 3717 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20040106632.pdf [firstpage_image] =>[orig_patent_app_number] => 10470980 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7061749 [patent_doc_number] => 20050004111 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-06 [patent_title] => 'Selective MMP-13 inhibitors' [patent_app_type] => utility [patent_app_number] => 10/751545 [patent_app_country] => US [patent_app_date] => 2004-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7487 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20050004111.pdf [firstpage_image] =>[orig_patent_app_number] => 10751545 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7288209 [patent_doc_number] => 20040147512 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-29 [patent_title] => 'Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4' [patent_app_type] => new [patent_app_number] => 10/748089 [patent_app_country] => US [patent_app_date] => 2003-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 67195 [patent_no_of_claims] => 74 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20040147512.pdf [firstpage_image] =>[orig_patent_app_number] => 10748089 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7310712 [patent_doc_number] => 20040142975 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-22 [patent_title] => 'Beta disubstituted metalloprotease inhibitors' [patent_app_type] => new [patent_app_number] => 10/744346 [patent_app_country] => US [patent_app_date] => 2003-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18754 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20040142975.pdf [firstpage_image] =>[orig_patent_app_number] => 10744346 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7325325 [patent_doc_number] => 20040138194 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-15 [patent_title] => 'Equilenin derivatives, methods for producing the same and medicaments containing them' [patent_app_type] => new [patent_app_number] => 10/743924 [patent_app_country] => US [patent_app_date] => 2003-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3261 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20040138194.pdf [firstpage_image] =>[orig_patent_app_number] => 10743924 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5638135 [patent_doc_number] => 20060069109 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-30 [patent_title] => 'Therapeutic agents' [patent_app_type] => utility [patent_app_number] => 10/540348 [patent_app_country] => US [patent_app_date] => 2003-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21543 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20060069109.pdf [firstpage_image] =>[orig_patent_app_number] => 10540348 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7447860 [patent_doc_number] => 20040186115 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-23 [patent_title] => 'Compositions useful as inhibitors of protein kinases' [patent_app_type] => new [patent_app_number] => 10/738965 [patent_app_country] => US [patent_app_date] => 2003-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18321 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20040186115.pdf [firstpage_image] =>[orig_patent_app_number] => 10738965 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 151760 [patent_doc_number] => 07683069 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-23 [patent_title] => '3-substituted-4-pyrimidone derivatives' [patent_app_type] => utility [patent_app_number] => 10/538766 [patent_app_country] => US [patent_app_date] => 2003-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10364 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/683/07683069.pdf [firstpage_image] =>[orig_patent_app_number] => 10538766 [rel_patent_id] =>[rel_patent_doc_number] =>)